Browse studies

Find your next paid study

1 recruiting study matching your filters

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

This is a randomized, double-blind, placebo-controlled basket trial evaluating mifomelatide (TCMCB07) administered daily by subcutaneous (SC) injection in up t…

Cancer Weight Loss

Estimated

~$10 – $7,500

Endevica BioNCT06937177